MCO vs ORMP
Moodys Corporation (MCO) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Moodys Corporation (MCO) is a financial data & stock exchanges company listed on NYSE.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MCO revenue for 2025-12-31 was $7.72B. Net income was $2.46B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. MCO currently screens at market cap $79.69B and trailing P/E 32.7.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MCO currently screens at market cap $79.69B and trailing P/E 32.7. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MCO and ORMP stock pages for the full models.
Not investment advice.